|
|
Volumn 23, Issue 2, 1995, Pages 199-208
|
|
The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies
a
|
|
Author keywords
cytochromes P 450; Drug metabolism; hepatocytes; liver slices; microsomes; Phase I enzymes; Phase II enzymes; zatosetron
|
|
Indexed keywords
4 METHYLPYRAZOLE;
ALCOHOL;
ALPHA NAPHTHOFLAVONE;
BARBITURIC ACID DERIVATIVE;
CHLORZOXAZONE;
CYCLOSPORIN;
CYTOCHROME P450;
DEXAMETHASONE;
DISULFIRAM;
FURAFYLLINE;
GESTODENE;
ISONIAZID;
KETOCONAZOLE;
MIDAZOLAM;
PHENYTOIN;
QUERCETIN;
QUINIDINE;
RIFAMPICIN;
SULFAPHENAZOLE;
TRANYLCYPROMINE;
TROLEANDOMYCIN;
ZATOSETRON;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ANXIETY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG METABOLISM;
DRUG SAFETY;
DRUG THERAPY;
ENZYME ACTIVITY;
ENZYME ISOLATION;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
HUMAN TISSUE;
LIVER CELL;
NONHUMAN;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RAT;
RISK ASSESSMENT;
TOXICOKINETICS;
ANIMALIA;
|
|
EID: 0029156695
PISSN: 01926233
EISSN: None
Source Type: Journal
DOI: 10.1177/019262339502300214 Document Type: Conference Paper |
|
Times cited : (80)
|
|
References (0)
|
